NIA-AA Symposium: Enabling Precision Medicine for Alzheimer's Disease Through Open Science

Pre-recorded event: Available on-demand starting Monday, July 27, 2020
Live session: Friday, July 31, 2020 at 8:30 a.m. Central Daylight Time (North America)

Overview

This symposium will feature an array of translational research programs that integrate computational and experimental approaches to:

  1. Discover novel, disease-relevant targets and biomarkers.
  2. Develop next-generation animal models and target enabling tools.
  3. Support the development of new candidate therapeutics for a diverse portfolio of targets.
  4. Advance data-driven drug repositioning and combination therapy development.

The featured programs will include:

Agenda

View the agenda.

Target Audience

Academic, biotech and pharmaceutical industry researchers with interest in target and biomarker discovery, preclinical and clinical drug development; computational biologists; data scientists; and open science advocates.

Scheduling Note

Pre-recorded materials will become available on-demand beginning Monday, July 27. Live sessions will be held on Friday, July 31. All times are listed in Central Daylight Time (North America).

All pre-recorded content will be available for 30 days after the conference. ISTAART members receive extended access to the virtual platform for an additional 30 days following AAIC. Not an ISTAART member? Join today.

Become an ISTAART Member

Go beyond the conference — Network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.


JOIN NOW

Join the Conversation #AAIC20

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs